Literature DB >> 5587

Differential pulse polarographic assay procedure and in vitro biopharmaceutical properties of dipotassium clorazepate.

C W Abruzzo, M A Brooks, S Cotler, S A Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 5587     DOI： 10.1007/BF01271442

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  4 in total

1.  Determination of 1,4-benzodiazepines in biological fluids by differential pulse polarography.

Authors:  M A Brooks; J A de Silva
Journal:  Talanta       Date:  1975 October - November       Impact factor: 6.057

2.  [Determination of dipotassium chlorazepate (author's transl)].

Authors:  H Oelschläger; F I Sengün
Journal:  Arch Pharm (Weinheim)       Date:  1974-06       Impact factor: 3.751

3.  Determination of glibornuride (a tolylsulfonyl urea hypoglycemic agent) in blood by differential pulse polarography.

Authors:  J A De Silva; M R Hackman
Journal:  Anal Chem       Date:  1972-06       Impact factor: 6.986

4.  Use of cannulated everted intestinal sac for serial sampling as a drug absorbability (permeability) screen.

Authors:  S A Kaplan; S Cotler
Journal:  J Pharm Sci       Date:  1972-09       Impact factor: 3.534
  4 in total
  1 in total

1.  Changes in the oral absorption characteristics in man of dipotassium clorazepate at normal and elevated gastric pH.

Authors:  C W Abruzzo; T Macasieb; R Weinfeld; J A Rider; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.